Skip to main content
. 2012 Aug 9;2012:930487. doi: 10.1155/2012/930487

Table 6.

The influence of degree of macrovesicular steatosis on protective effects of sevoflurane preconditioning.

Macrovesicular steatosis Incidence of EAD, % Fisher's exact test, two-tailed P value
Sevoflurane group Control group
None (0%) 11,1 (1 of 9) 11,1 (1 of 9) 1,000
Mild (1–30%) 18,8 (3 of 16) 60,0 (9 of 15) 0,029
Moderate (31–60%) 20,0 (1 of 5) 83,3 (5 of 6) 0,080

EAD: early allograft dysfunction.